HDAC6 and chronic obstructive pulmonary disease: These data, together with previous findings that small-molecule compounds inhibiting HDAC6 restore ciliary defects in nephronophthisis and chronic obstructive pulmonary disease [18, 26], suggest the potential therapeutic value of HDAC6-selective inhibitors in ciliopathies.